Thursday, September 20, 2018

google plus

Posted at: Mar 9, 2018, 1:45 AM; last updated: Mar 9, 2018, 12:18 PM (IST)

4 bio-sanitary pads for Rs10 at Jan Aushadhi centres

Govt chooses International Women’s Day to launch centrally-sourced-and-distributed pads
4 bio-sanitary pads for Rs10 at Jan Aushadhi centres

Aditi Tandon

Tribune News Service

New Delhi, March 8

Menstrual hygiene just took centrestage. After months of debate around exempting sanitary napkins from the Goods and Services Tax (GST) net, the government today chose the occasion of International Women’s Day to launch centrally-sourced and distributed low-cost biodegradable sanitary pads for anyone who would care to use. A set of four such pads will cost Rs 10 and will be easy to use and dispose of on account of biodegradability.

(Follow The Tribune on Facebook; and Twitter @thetribunechd)

Called “Suvidha”, these will be sold through the government’s drug dispensing stores called Jan Aushadhi Kendras. There are 3,200 such kendras across 586 districts today — a massive expansion from 99 similar outlets in 2014.

The launch is revolutionary for India’s ongoing cleanliness campaign and also for its virtually negligible cost.

One pad will cost just Rs 2.50 as against the current average cost of Rs  8 for a non- biodegradable napkin of companies like Whisper, Stayfree and Carefree.

Launching the product close on the heels of release of Akshay Kumar-starrer Padman, which helped focus attention on the issue, Chemicals and Fertilisers Minister Ananth Kumar said, “These napkins will address three challenges of health, convenience and cleanliness — swasthya, suvidha and swachhta.”

He also cited the prices of a set of four napkins currently being marketed by the above mentioned players and added, “No woman would now have to use unhygienic health accessories for the want of being unable to afford these.”

The availability of low-cost health products in the form of sanitary napkins is the fourth in the line of other similar products whose prices were slashed over the recent past.

These include 800 drug formulations to cure a range of non-communicable diseases, cardiac stents and orthopaedic implants. 

The Central Government is now reviewing possibilities of capping the prices of ocular lenses.


All readers are invited to post comments responsibly. Any messages with foul language or inciting hatred will be deleted. Comments with all capital letters will also be deleted. Readers are encouraged to flag the comments they feel are inappropriate.
The views expressed in the Comments section are of the individuals writing the post. The Tribune does not endorse or support the views in these posts in any manner.
Share On